Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 6:07 pm Purchase |
2025-03-31 | 13G | Universe Pharmaceuticals INC UPC |
Anson Funds Management LP | 234,374 1.000% |
214,816 (+1098.34%) |
Filing History |
| 2025-05-15 5:23 pm Purchase |
2025-03-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Anson Funds Management LP | 595,719 9.900% |
595,538 (+328311.63%) |
Filing History |
| 2025-05-15 5:15 pm Purchase |
2025-03-31 | 13G | NRx Pharmaceuticals, Inc. NRXP |
Anson Funds Management LP | 1,179,061 7.000% |
1,179,061 (New Position) |
Filing History |
| 2025-05-15 5:14 pm Purchase |
2025-03-31 | 13G | Applied DNA Sciences, Inc. APDN |
Anson Funds Management LP | 209,469 5.400% |
207,945 (+13643.42%) |
Filing History |
| 2025-05-15 5:05 pm Sale |
2025-03-31 | 13G | SRM Entertainment, Inc. SRM |
Anson Funds Management LP | 0 0.000% |
-1,395,235 (Position Closed) |
Filing History |
| 2025-05-15 5:03 pm Purchase |
2025-03-31 | 13G | Sharps Technology, Inc. STSS |
Anson Funds Management LP | 1,800,000 9.900% |
1,800,000 (New Position) |
Filing History |
| 2025-05-15 4:59 pm Purchase |
2025-03-31 | 13G | SELLAS Life Sciences Group, Inc. SLS |
Anson Funds Management LP | 7,579,095 8.300% |
7,579,095 (New Position) |
Filing History |
| 2025-05-15 4:57 pm Purchase |
2025-03-31 | 13G | Femto Technologies Inc. FMTO |
Anson Funds Management LP | 324,808 9.900% |
324,808 (New Position) |
Filing History |
| 2025-05-15 4:56 pm Purchase |
2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD |
Anson Funds Management LP | 5,639,090 9.900% |
5,639,090 (New Position) |
Filing History |
| 2025-05-15 4:34 pm Purchase |
2025-03-31 | 13G | Cyngn Inc. CYN |
Anson Funds Management LP | 77,639 4.200% |
62,837 (+424.53%) |
Filing History |
| 2025-05-15 4:32 pm Purchase |
2025-03-31 | 13G | Greenwave Technology Solutions, Inc. GWAV |
Anson Funds Management LP | 4,843,160 8.000% |
3,810,748 (+369.11%) |
Filing History |
| 2025-05-15 4:21 pm Purchase |
2025-03-31 | 13G | 180 Life Sciences Corp. ATNF |
Anson Funds Management LP | 245,750 4.500% |
20,479 (+9.09%) |
Filing History |
| 2025-05-15 4:12 pm Sale |
2025-03-31 | 13G | 22nd Century Group, Inc. XXII |
Anson Funds Management LP | 176,094 7.400% |
-2,256,126 (-92.76%) |
Filing History |
| 2025-05-15 3:17 pm Purchase |
2025-03-31 | 13G | Datavault AI Inc. DVLT |
Anson Funds Management LP | 3,214,941 4.900% |
2,861,820 (+810.44%) |
Filing History |
| 2025-04-14 08:30 am Purchase |
2025-04-10 | 13D | The Lovesac Company LOVE |
Anson Funds Management LP | 1,045,665 7.100% |
113,404 (+12.16%) |
Filing History |
| 2025-03-25 11:45 am Purchase |
2025-03-13 | 13D | The Lovesac Company LOVE |
Anson Funds Management LP | 932,261 6.000% |
117,898 (+14.48%) |
Filing History |
| 2025-02-14 7:10 pm Purchase |
2024-12-31 | 13G | PMGC Holdings Inc. ELAB |
Anson Funds Management LP | 151,501 4.900% |
149,900 (+9364.25%) |
Filing History |
| 2025-02-14 6:36 pm Purchase |
2024-12-31 | 13G | 180 Life Sciences Corp. ATNF |
Anson Funds Management LP | 225,271 7.100% |
225,271 (New Position) |
Filing History |
| 2025-02-14 6:32 pm Unchanged |
2024-12-31 | 13G | Cyngn Inc. CYN |
Anson Funds Management LP | 14,802 9.900% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:30 pm Purchase |
2024-12-31 | 13G | Oncolytics Biotech Inc. ONCY |
Anson Funds Management LP | 8,185,743 9.600% |
8,185,743 (New Position) |
Filing History |